Funder: National Institutes of Health
Due Dates: April 9, 2025 | August 6, 2025 | December 5, 2025 (all: New, Renewal, Resubmission, Revision)
Funding Amounts: Up to $300,000 direct costs per year, for a maximum of 4 years per project
Summary: Supports time-sensitive ancillary studies leveraging ongoing clinical projects (no clinical trials) to enhance scientific value and maximize existing investments.
Key Information: Accelerated review/award process; must justify time-sensitivity and obtain parent project approval.